Cullinan Associates Inc. Has $32.60 Million Holdings in Procter & Gamble Company (The) $PG

Key Points

• Cullinan Associates Inc. trimmed its Procter & Gamble stake by 12.9% in the first quarter, selling 33,337 shares and leaving it with 225,713 shares valued at about $32.6 million.
• Procter & Gamble reported solid quarterly results, with earnings per share of $1.59 beating estimates, while revenue rose 7.4% year over year to $21.23 billion. The company also raised its quarterly dividend to $1.0885 per share.
• Analyst sentiment remains broadly positive, with several firms reiterating Buy or Outperform ratings even as some lowered price targets; the consensus rating is Moderate Buy with an average target of $161.42.

Cullinan Associates Inc. reduced its stake in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 12.9% during the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 225,713 shares of the company's stock after selling 33,337 shares during the period. Procter & Gamble makes up approximately 2.6% of Cullinan Associates Inc.'s holdings, making the stock its 8th biggest holding. Cullinan Associates Inc.'s holdings in Procter & Gamble were worth $32,602,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in PG. E Fund Management Hong Kong Co. Ltd. lifted its stake in Procter & Gamble by 1,000.0% in the 4th quarter. E Fund Management Hong Kong Co. Ltd. now owns 165 shares of the company's stock valued at $25,000 after acquiring an additional 150 shares in the last quarter. Litman Gregory Wealth Management LLC acquired a new stake in shares of Procter & Gamble in the fourth quarter valued at approximately $26,000. Park Square Financial Group LLC lifted its position in shares of Procter & Gamble by 65.1% in the fourth quarter. Park Square Financial Group LLC now owns 180 shares of the company's stock worth $26,000 after purchasing an additional 71 shares in the last quarter. Evolution Wealth Management Inc. grew its position in Procter & Gamble by 1,315.4% in the fourth quarter. Evolution Wealth Management Inc. now owns 184 shares of the company's stock valued at $26,000 after purchasing an additional 171 shares in the last quarter. Finally, Basso Capital Management L.P. acquired a new stake in Procter & Gamble in the 4th quarter valued at $28,000. Institutional investors and hedge funds own 65.77% of the company's stock.

Trending Headlines about Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: RBC Capital reportedly initiated/maintained a Buy rating on Procter & Gamble, reinforcing confidence in the company’s defensive earnings profile and dividend stability.
• Positive Sentiment: Bank of America kept a Buy rating on PG while lowering its price target to $166 from $170, still implying meaningful upside from current levels.
• Positive Sentiment: Recent commentary highlighted PG as a Dividend King with a long history of dividend growth, plus product launches such as Braun NEVO and Cascade Clean and Dry Booster Rinse Aid that could support brand momentum.
• Neutral Sentiment: Several market recap pieces noted that PG had recently underperformed the broader market in prior sessions, reflecting some near-term pressure rather than a company-specific shock.
• Neutral Sentiment: Other articles focused broadly on dividend investing strategies and retirement income ideas, using PG as an example of a reliable income stock rather than citing a new business catalyst.
• Negative Sentiment: One article framed PG as facing a “fresh market test,” suggesting investors are still assessing whether its valuation and growth outlook justify renewed buying.

Procter & Gamble Stock Performance

NYSE PG traded up $0.30 on Friday, reaching $147.15. The stock had a trading volume of 12,472,118 shares, compared to its average volume of 8,997,727. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.73 and a quick ratio of 0.53. The company has a market cap of $342.65 billion, a P/E ratio of 21.51, a price-to-earnings-growth ratio of 6.25 and a beta of 0.39. The firm has a fifty day moving average of $146.58 and a two-hundred day moving average of $148.37. Procter & Gamble Company has a 1-year low of $137.62 and a 1-year high of $167.25.

Procter & Gamble (NYSE:PG - Get Free Report) last posted its earnings results on Friday, April 24th. The company reported $1.59 earnings per share for the quarter, topping analysts' consensus estimates of $1.56 by $0.03. Procter & Gamble had a return on equity of 32.00% and a net margin of 19.16%.The company had revenue of $21.23 billion during the quarter, compared to the consensus estimate of $21.52 billion. During the same quarter last year, the firm earned $1.54 earnings per share. The company's revenue was up 7.4% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, equities research analysts anticipate that Procter & Gamble Company will post 6.89 EPS for the current year.

Procter & Gamble Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, May 15th. Stockholders of record on Friday, April 24th were issued a dividend of $1.0885 per share. This is a boost from Procter & Gamble's previous quarterly dividend of $1.06. This represents a $4.35 annualized dividend and a dividend yield of 3.0%. The ex-dividend date of this dividend was Friday, April 24th. Procter & Gamble's payout ratio is 63.60%.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the company. Bank of America decreased their price objective on Procter & Gamble from $170.00 to $166.00 and set a "buy" rating for the company in a report on Friday. Piper Sandler upped their target price on shares of Procter & Gamble from $142.00 to $145.00 and gave the company a "neutral" rating in a report on Friday, April 24th. Raymond James Financial reduced their price target on Procter & Gamble from $175.00 to $170.00 and set an "outperform" rating for the company in a report on Tuesday, April 14th. BNP Paribas Exane lowered their price target on Procter & Gamble from $172.00 to $165.00 and set an "outperform" rating on the stock in a research report on Thursday, April 23rd. Finally, Morgan Stanley cut their price objective on Procter & Gamble from $175.00 to $166.00 and set an "overweight" rating for the company in a research report on Wednesday, April 22nd. Twelve research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $161.42.

About Procter & Gamble

Procter & Gamble NYSE: PG is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world's largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G's product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.